In this Genetic Engineering & Biotechnology article, Quentin Perron, CSO and Co-Founder at Iktos, shares how AI and robotics are revolutionizing drug design—alongside leaders from Exscientia, DeepCure, and VeriSIM Life.
Please follow this link to access the article.
